Skip to content

   Pharma Publications

Neuropsychopharmacology
  • IN MEMORIAM: Floyd E. Bloom, M.D
    Published on 2025-03-04
    2 years ago
  • Persistent brain network signatures in psychosis: implications for diagnosis, prognosis, and treatment
    Published on 2025-03-04
    2 years ago
  • Central Executive Network drives delta-9-tetrahydrocannabinol (THC)-induced nonlinear changes in large-scale functional connectivity in adolescent nonhuman primates
    Published on 2025-02-27
    2 years ago
  • A new module in the drug development process: preclinical multi-center randomized controlled trial of R-ketamine on alcohol relapse
    Published on 2025-02-27
    2 years ago
  • The prelimbic prefrontal cortex mediates the development of lasting social avoidance as a consequence of social threat conditioning
    Published on 2025-02-26
    2 years ago
  • A projection from the medial prefrontal cortex to the lateral septum modulates coping behavior on the shock-probe test
    Published on 2025-02-26
    2 years ago
  • Pharmacological reduction of reverse-translated hippocampal hyperactivity in mouse: relevance for psychosis
    Published on 2025-02-26
    2 years ago
« Previous 1 … 68 69 70 71 72 … 143 Next »
Journal of Psychopharmacology
  • Low-frequency monitoring for community clozapine initiations: A comparative study relative to standard frequency assessments
    Published on 2023-05-12
    3 years ago
  • Pharmacological characterization of the selective orexin-1 receptor antagonist JNJ-61393215 in healthy volunteers
    Published on 2023-05-11
    3 years ago
  • Sub-anesthetic doses of ketamine increase single cell entrainment in the rat auditory cortex during auditory steady-state response
    Published on 2023-05-11
    3 years ago
  • Comment on ‘Characteristics of poisonings involving ketamine in the United States, 2019–2021’
    Published on 2023-05-03
    3 years ago
  • Marketing pitches of ‘magic mushrooms’ and ‘psychedelics’ mask that psychotomimetics use exposes those vulnerable to serious adverse effects
    Published on 2023-05-03
    3 years ago
  • Effect of CannEpil® on simulated driving performance and co-monitoring of ocular activity: A randomised controlled trial
    Published on 2023-05-02
    3 years ago
  • Behavioral profile of adult zebrafish acutely exposed to a selective dopamine uptake inhibitor, GBR 12909
    Published on 2023-04-26
    3 years ago
« Previous 1 … 68 69 70 71 72 … 154 Next »
European Neuropsychopharmacology
  • The impact of the COVID-19 pandemic on ADHD medicine consumption in 47 countries and regions
    Published on 2023-04-17
    3 years ago
  • Antidepressant efficacy of cariprazine in bipolar disorder and the role of its pharmacodynamic properties: A hypothesis based on data
    Published on 2023-04-14
    3 years ago
  • Inflammatory disequilibrium and lateral ventricular enlargement in treatment-resistant schizophrenia
    Published on 2023-04-13
    3 years ago
  • Psychotropic drugs consumption during 2020 COVID-19 pandemic and lockdowns: Evidence of a surprising resilience of the drugs delivery system in France.
    Published on 2023-04-11
    3 years ago
  • Kappa opioid activation changes protein profiles in different regions of the brain relevant to depression
    Published on 2023-04-09
    3 years ago
  • Intranasal administration of olanzapine has beneficial outcome in a rat activity-based anorexia model
    Published on 2023-04-08
    3 years ago
  • Repurposing selective serotonin reuptake inhibitors for severity of COVID-19: a population-based study
    Published on 2023-04-05
    3 years ago
« Previous 1 … 68 69 70 71 72 … 170 Next »

   Pharma Pub